Article
Published 1 Aug 2025
The New EU "Pharma Package": Global (Orphan) Marketing Authorization
Crowell & Moring LLP
Your search returned 65 results
Refine Your Search
Search Results
- Relevance
- Newest
- Oldest
Article
Published 29 Jul 2025
The New EU "Pharma Package": The Debate On Fiscal Import In The Supply Chain
Crowell & Moring LLP
Article
Published 21 Jul 2025
The New EU "Pharma Package": The Transferable Exclusivity Voucher—A Comparison Of Commission/Parliament/Council Positions
Crowell & Moring LLP
Article
Published 15 Jul 2025
The New EU "Pharma Package": Regulatory Data Protection – A Comparison Of Commission/Parliament/Council Positions
Crowell & Moring LLP
Article
Published 4 Jul 2025
European Commission Consultation Shapes High-risk AI Classification For Life Sciences In The EU
Osborne Clarke
Article
Published 4 Jul 2025
EU Guidance Details How Technical And Clinical Standards Converge For AI In Medtech
Osborne Clarke
Article
Published 2 Jul 2025
The New EU "Pharma Package": Preparing For The Trilogues
Crowell & Moring LLP
Article
Published 19 Jun 2025
Council Position On EU Pharma Package Adopted
A&O Shearman
Article
Published 4 Jun 2025
EU Geopolitical Risk Update - Key Policy & Regulatory Developments No. 121
Jones Day
Article
Published 14 Feb 2025
EU Geopolitical Risk Update - Key Policy & Regulatory Developments No. 119
Jones Day
Article
Published 16 Jan 2025
Brussels Enterprise Court Clarifies Requirements For SPC Manufacturing Waiver
A&O Shearman
Article
Published 2 Jan 2025
The European Commission Launches Public Consultation On The MDR And IVDR
Arnold & Porter
Article
Published 17 Dec 2024
Belgium Creates A New Legal Exemption For Unauthorised Medicines
Osborne Clarke
Article
Published 16 Oct 2024
European Medicines Agency Issues Guidance On AI Use In Pharma Regulatory Science
Osborne Clarke
Article
Published 2 Oct 2024
Draghi Report On EU Competitiveness Offers New Recommendations For Pharma And Biotech
Osborne Clarke
Article
Published 26 Jul 2024
Preparing For The EU's New Approach To Critical Medicines And Medicine Shortages: A New 'Critical Medicines Act'?
Crowell & Moring LLP
Article
Published 25 Jun 2024
Brussels Court Of Appeal Prohibits The Rebranding Of A Generic Pharmaceutical Into The Originator Reference Product In The Framework Of Parallel Import
Crowell & Moring LLP
Article
Published 23 May 2024
Future Foods Update | May 2024
Osborne Clarke
Article
Published 17 May 2024
HFSS Newsletter | May 2024
Osborne Clarke
Article
Published 10 May 2024
EU Court Of Justice Interprets Import Ban On Chinese Animal Products: Fish Oil For Feed Is Not An Exempted "Fishery Product"
Altius